IP Library Granted Patent US 9,657,317
Granted Patent B2
US 9,657,317 · App. 14/344,899 · Granted May 23, 2017

Host cells and method for making acrylate and precursors thereof using an odd-numbered alkane feedstock

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,657,317
App. No.
14/344,899
Granted
May 23, 2017
Kind
B2
Abstract

Provided herein is an alkane-metabolizing cell that is unable to convert propionyl-CoA into methylmalonyl-CoA or 2-metylcitrate synthase. Depending on which enzymes are present in the cell, the cell can produce acrylate or a precursor for the same (e.g., propionate, 3-hydroxypropionyl-CoA, 3-hydroxypropionate, acrylyl-CoA) that can be readily converted to acrylate enzymatically (e.g., in the cell) or by chemical treatment. In one embodiment, the cell may contain a cytochrome P450 or alkane oxidase enzyme that allows the production of 3-hydroxypropionyl-CoA, which can be readily converted to 3-hydroxypropionate. In order to make such compounds, the cell may be grown in the presence of an odd-numbered chain alkane (e.g., pentane or heptane), although another odd-numbered chain alkane may be used. In another embodiment, the cell may contain acyl-CoA oxidase, enoyl-CoA hydratase, and hydrolase.

Claims (35)

1. A genetically engineered alkane-metabolizing bacteria or yeast, comprising:

(a) a polynucleotide encoding an enzyme that can hydroxylate an omega carbon of an alkane or a β-oxidation product thereof; and

(b) a genetic alteration to a polynucleotide encoding a propionyl-CoA carboxylase, to a polynucleotide encoding a 2-methylcitrate synthase, or to both, wherein the genetic alteration inactivates the encoded propionyl-CoA carboxylase, 2-methylcitrate synthase, or both,

wherein the genetically engineered alkane-metabolizing bacteria or yeast accumulate an increased level of propionyl-CoA when cultured in the presence of the alkane under conditions and for a time sufficient to produce propionyl-CoA as compared to a parent bacteria or yeast, respectively, cultured under the same conditions.

2. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the alkane is pentane and the enzyme that can hydroxylate the omega carbon of the alkane or β-oxidation product thereof is selected from:

(a) an enzyme capable of converting pentane to 5-hydroxypentane;

(b) an enzyme capable of converting pentanoic acid to 5-hydroxypentanoic acid;

(c) an enzyme capable of converting pentanyl-CoA into 5-hydroxypentanyl CoA; or

(d) an enzyme capable of converting propionyl-CoA to 3-hydroxypropionyl CoA.

3. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the enzyme that can hydroxylate the omega carbon of the alkane or β-oxidation product thereof has an amino acid sequence that is at least 80% identical to the amino acid sequence of a cytochrome P450 enzyme selected from Table 1, or is an alkane oxidase enzyme.

4. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the enzyme that can hydroxylate an omega carbon of an alkane or a β-oxidation product thereof is native to the bacteria or yeast.

5. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the enzyme that can hydroxylate the omega carbon of an alkane or a β-oxidation product thereof is non-native to the bacteria or yeast.

6. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , further comprising a 3-hydroxyisobutyryl-CoA hydrolase capable of converting 3-hydroxypropionyl CoA to 3-hydroxypropionate.

7. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , further comprising a propionyl-CoA dehydrogenase capable of converting propionyl-CoA to acrylyl-CoA.

8. The genetically engineered alkane-metabolizing bacteria or yeast of claim 7 , further comprising a 3-hydroxypropionyl-CoA dehydratase capable of converting the acrylyl-CoA to 3-hydroxypropionyl-CoA.

9. The genetically engineered alkane-metabolizing bacteria or yeast of claim 7 , further comprising an acyl-CoA hydrolase capable of converting acrylyl-CoA to acrylate.

10. The genetically engineered alkane-metabolizing bacteria or yeast of claim 9 , further comprising a genetic alteration to a polynucleotide encoding a 3-hydroxypropionyl-CoA dehydratase, to a polynucleotide encoding a lactyl-CoA dehydratase, or to both, wherein the genetic alteration inactivates, respectively, the 3-hydroxypropionyl-CoA dehydratase, the lactyl-CoA dehydratase, or both.

11. The genetically engineered alkane-metabolizing bacteria or yeast of claim 7 , further comprising a 3-hydroxyisobutyryl-CoA hydrolase capable of converting 3-hydroxypropionyl-CoA to 3-hydroxypropionate.

12. The genetically engineered alkane-metabolizing bacteria or yeast of claim 11 , further comprising a genetic alteration that to a polynucleotide encoding: (a) a 3-hydroxyisobutyrate dehydrogenase; (b) an aldehyde dehydrogenase; (c) an acetyl-CoA carboxylase; (d) a malonyl-CoA reductase; or (e) any combination thereof, wherein the genetic alteration inactivates the encoded enzyme(s) of (a) to (e).

13. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , further comprising genetic alteration to a polynucleotide encoding: (a) a 3-hydroxyisobutyrate dehydrogenase; (b) an aldehyde dehydrogenase; (c) an acetyl-CoA carboxylase; (d) a malonyl-CoA reductase; (e) a 3-hydroxypropionyl-CoA dehydratase; (f) a lactyl-CoA dehydratase, or (g) any combination thereof, wherein the genetic alteration inactivates the encoded enzyme(s) of (a) to (g).

14. The genetically engineered alkane-metabolizing bacteria or yeast of claim 13 , wherein the genetically engineered alkane-metabolizing bacteria or yeast accumulates an increased level of propionyl-CoA when the genetically engineered alkane metabolizing bacteria or yeast is cultured in the presence of the alkane under conditions and for a time sufficient to produce propionyl-CoA as compared to the genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , respectively, cultured under the same conditions.

15. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the genetic alteration results in an inactivated propionyl-CoA carboxylase gene, an inactivated 2-methylcitrate synthase gene, or both.

16. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the genetically engineered alkane-metabolizing bacteria or yeast is a genetically engineered alkane-metabolizing bacteria.

17. The genetically engineered alkane-metabolizing bacteria or yeast of claim 16 , wherein the genetically engineered alkane-metabolizing bacteria is from a genus of Pseudomonas, Corynebacterium , or Rhodococcus.

18. The genetically engineered alkane-metabolizing bacteria or yeast of claim 1 , wherein the genetically engineered alkane-metabolizing bacteria or yeast is a genetically engineered alkane-metabolizing yeast.

19. The genetically engineered alkane-metabolizing bacteria or yeast of claim 18 , wherein the genetically engineered alkane-metabolizing yeast is from a genus of Candida, Yarrowia , or Saccharomyces.

20. A method for making 3-hydroxypropionate or acrylate, comprising culturing the genetically engineered alkane-metabolizing bacteria or yeast of claim 1 in a culture medium comprising an odd numbered chain alkane for a time sufficient to allow the genetically engineered alkane-metabolizing bacteria or yeast to produce 3-hydroxypropionyl CoA or acrylyl-CoA.

21. The method of claim 20 , wherein the odd-numbered chain alkane is a heptane, a pentane or a propane.

22. The method of claim 20 , further comprising harvesting the genetically engineered alkane-metabolizing bacteria or yeast and generating a lysate of the harvested genetically engineered alkane-metabolizing bacteria or yeast.

23. The method of claim 22 , further comprising isolating 3-hydroxypropionyl-CoA or acrylyl-CoA from the lysate.

24. The method of claim 22 , further comprising treating the lysate with an acid or base, thereby hydrolyzing the 3-hydroxypropionyl-CoA to produce the 3-hydroxypropionate or thereby hydrolyzing the acrylyl-CoA to produce acrylate.

25. The method of claim 24 , further comprising converting the 3-hydroxypropionate to acrylate.

26. The method of claim 20 , further comprising treating the culture medium with an acid or base, thereby hydrolyzing the 3-hydroxypropionyl-CoA to produce 3-hydroxypropionate or thereby hydrolyzing the acrylyl-CoA to produce acrylate.

27. The method of claim 26 , further comprising converting the 3-hydroxypropionate to acrylate.

28. The method of claim 20 , wherein the enzyme that can hydroxylate the omega carbon of the alkane or β-oxidation product thereof has an amino acid sequence that is at least 80% identical to the amino acid sequence of a cytochrome P450 enzyme selected from Table 1, or is an alkane oxidase enzyme.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 12, 2025
From: VENTURE LENDING & LEASING IX, INC.
To: CALYSTA, INC.
Reel/Frame 072242/0047 →
SECURITY INTEREST Recorded Oct 7, 2024
From: CALYSTA, INC.
To: AQUA-SPARK CALYSTA LLC
Reel/Frame 069116/0150 →
SECURITY INTEREST Recorded Feb 29, 2024
From: CALYSTA, INC.
To: OCEAN 14 CAPITAL FUND 1 SCSP
Reel/Frame 066607/0888 →
SECURITY INTEREST Recorded Aug 27, 2021
From: CALYSTA, INC.
To: VENTURE LENDING & LEASING IX, INC.
Reel/Frame 057337/0355 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 19, 2014
From: SILVERMAN, JOSHUA A.; PURCELL, TOM; NESS, JON EDWARD; LEONARD, EFFENDI
To: CALYSTA, INC.
Reel/Frame 034209/0935 →